Hi Kiwifoot,
thanks for posting this. This study and its findings form a good example of how misleading such things can be. While on the surface this reported 31%
reduction in infection looks promising, they have skewed the figures in a very un-scientific way by only considering those test subjects who actually
became infected. What they should have done is shown the infection rates as percentages relative to both the trial (innoculated) group and the placebo
group. Then we would see if there is a statistically significant result that might be attributable to the vaccine.
You have probably seen how infection rates for "swine flu" and other epidemics/pandemics are quoted both as net figures -- ie actual cases logged --
and as infections/100,000 of population. That is the correct way to do it, because without including the data of the size of the total subject
group, the whole thing becomes misleading at best and meaningless at worst.
According to that article which summarizes the HIV Vaccine Trial, 8,197 people were given the vaccine and 8,198 were given a placebo. After three
years, 51 of the vaccinated group had become infected with HIV, compared to 74 of the placebo group. So, let's look at the percentages of those
infected in relation to all the people who participated in the study.
Percentages (Numbers rounded to 2 sig figs):
Of the vaccine group of 8,197, 0.62% (51) became infected -- and 99.38% (8146) did not.
Of the placebo group of 8,198, 0.90% (74) became infected -- and 99.10% (8,124) did not.
Of the total group of 16,395, 0.76% (125) became infected -- and 99.24% (16,270) did not.
Statistically, then, for any person in the group chosen at random (with no knowledge of whether they were vaccinated or not), the chances of this
individual not being infected worked out at 99.24%, which is only 0.14% worse than if they were one of the vaccinated.
To put it another way, the vaccinated group only improved their odds of not being infected by 0.28%, compared to the placebo group. This is such a
small statistical difference that it falls well inside pure-chance variation. There has to be an allowance for variation due to chance because we are
dealing with humans and a communicable disease that's related to social behaviour, so even slight variations in the way the subjects behaved over
that three-year period would yield some differences in their infection risk. A net infection rate difference of 0.28% between the two groups is
negligible. It certainly wouldn't make me feel confident about using that vaccine as a protection against HIV infection.
This is why I say that their claim of 31% is misleading, because it only considers the participants who got infected, and not the two complete groups
who were being monitored for those three years.
But don't get me wrong: I applaud the efforts of these researchers in trying to do something to reduce the risk of HIV transmission, and also have
nothing but admiration for all the people who volunteered to take part in the study. I just feel that the researchers were clutching at straws when
they came up with that "31%" figure, and actually I suspect that the relatively low overall rate of infection in a high-risk region like Thailand
was probably due to the counselling that all participants received. If the participants had not received any counselling at all about HIV prevention
then the infection rates would likely have been higher -- and we might then have seen if the vaccine's effects were actually of any statistical
significance.
According to avert.org, the rate of HIV infection among adults in Thailand is over 1%, so as this studied group is well below that, the counselling
was probably a contributing positive factor.
(Ref: HIV and AIDS in Thailand )
Best regards,
Mike
[edit on 24/9/09 by JustMike]


But like you I’m not just skeptical, I’m appalled at the fact that even Dr Sanjay Gupta on CNN has presented
this story as if it’s a big deal -- and has quoted that “31%” figure, which he has to know is nonsensical and unscientific. Considering that Dr
Gupta’s name was put out as a possible US Surgeon General that’s disturbing. So yes, there are some shenanigans going on.
Doubtful that the pharma companies’ earnings/taxes could offset banking crisis losses by any appreciable amount, but every penny helps I guess.